Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$730,617,099
+$141,866,370 QoQ
Shares Held
13,427,993
-2.2% QoQ
Ownership
5.42%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#3
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,951,130,026 across 312 Biotechnology names. EXEL ranks #1 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $730,617,099 | 13,427,993 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $588,750,729 | 13,726,993 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $609,852,504 | 13,914,043 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $638,467,685 | 15,459,266 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $697,335,241 | 15,819,765 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $547,311,863 | 14,824,265 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $509,352,304 | 15,295,865 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $398,589,820 | 15,359,916 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $340,714,093 | 15,163,066 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $358,363,720 | 15,101,716 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $374,621,026 | 15,615,716 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $332,489,614 | 15,216,916 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $279,915,425 | 14,647,589 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $296,572,940 | 15,279,389 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $239,975,867 | 14,961,089 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $251,363,633 | 16,030,844 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $370,261,568 | 17,783,937 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $382,267,842 | 16,862,278 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $312,602,221 | 17,100,778 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $370,954,171 | 17,547,501 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $329,463,168 | 18,082,501 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $420,914,974 | 18,632,801 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $435,170,805 | 21,682,651 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $554,174,164 | 22,665,610 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $546,184,043 | 23,006,910 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $345,623,653 | 20,071,060 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||